Astragaloside II

Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.

Price Not Available 10 mg Astragaloside II Supplier Page

Catalog Number	T3924
Alternative Name(s)	Astrasieversianin VIII
Research Area	Stem Cells
Molecular Formula	C41H66O15
CAS#	84676-89-1
Purity	99.70%
SMILES	C(=O)(C)O[C@H]1[C@@H](OC[C@H]([C@@H]1O)O)O[C@H]1CC[C@]23C4(CC[C@]5([C@]([C@@H]4C[C@@H]([C@H]2C1(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C[C@@H]([C@@H]5[C@@]1(O[C@@H](CC1)C(C)(C)O)C)O)C)C)C3
Size	10 mg
Supplier Page	https://www.targetmol.com/compound/Astragaloside II
Additional Information	https://www.targetmol.com/datasheet/T3924